For research use only. Not for therapeutic Use.
SANT-1 (CAT: I011873) is a potent and selective inhibitor of the Sonic hedgehog (Shh) pathway, which has shown potential as an anticancer agent. The Shh pathway plays a crucial role in various biological processes, including cell growth, differentiation, and tissue development. In certain cancers, including acute myeloid leukemia (AML), aberrant activation of the Shh pathway has been observed, contributing to drug resistance and cancer stem cell maintenance. SANT-1 inhibits the activity of the Shh pathway, thereby interfering with the signaling cascade and potentially suppressing tumor growth and drug resistance in AML and other cancers.
Catalog Number | I011873 |
CAS Number | 304909-07-7 |
Synonyms | N-[(3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)methylene]-4-(phenylmethyl)-1-piperazinamine |
Molecular Formula | C23H27N5 |
Purity | ≥95% |
Target | Smo |
Solubility | >18.75mg/mL in DMSO |
Storage | Desiccate at +4°C |
IUPAC Name | (E)-N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenylpyrazol-4-yl)methanimine |
InChI | InChI=1S/C23H27N5/c1-19-23(20(2)28(25-19)22-11-7-4-8-12-22)17-24-27-15-13-26(14-16-27)18-21-9-5-3-6-10-21/h3-12,17H,13-16,18H2,1-2H3/b24-17+ |
InChIKey | FOORCIAZMIWALX-JJIBRWJFSA-N |
SMILES | CC1=C(C(=NN1C2=CC=CC=C2)C)C=NN3CCN(CC3)CC4=CC=CC=C4 |
Reference | 1. Cancer Lett. 2013 Aug 19;336(2):347-58. doi: 10.1016/j.canlet.2013.03.025. Epub <br> |